Kahira Pharmaceuticals & Chemical Industries Company

E£598.90As of Sun 8 Nov 2026, 12:00 UTC
EGX:CPCIHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 58.54%
Div yield 2.79%
ROE 47.65%
Pharmaceutical Preparations
Beta (5Y) 0.24
PE TTM 17.73
TSR TTM 124.55%
Mkt cap E£8.944B
ROIC 40.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£601
0.34%
319.80%
Sell 3|2|2|7|8
2Q26
3Q26
4Q26
1Q27
Earnings per shareE£
7.70
8.07
9.01
9.26
18.05%
18.74%
23.14%
16.11%
RevenueE£M
754.7
733.6
742.6
731.7
12.62%
7.50%
4.13%
1.54%
Peers (US$165.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.514
0.302
0.206
EBIT/Intx
0.722
0.337
0.425
Own earn%
(11.79)
(21.94)
(7.80)
Sh yield%
36.04
46.38
44.10
Owners
Insiders/Inst%
7.10
28.54
Short interest%
3.74
SBC / revenue%
0.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
17–22
$1 testx
—
Incr. ROIC%
4